| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +26% |
| 3Y CAGR | +9% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +12% |
| 3Y CAGR | +25% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,621.80 -44.10 (0.95%) | 21,329.88 | 29.01 | 5.08 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,684.20 -27.00 (1.00%) | 20,606.39 | 30.39 | 5.75 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,879.00 -38.00 (0.55%) | 17,317.75 | 102.09 | 19.84 | ||
Natco PharmaNATCOPHARM | ₹841.70 -7.50 (0.88%) | 15,211.80 | 13.29 | 1.65 |